MUSTANG BIO, INC. Operating Lease, Payments
MUSTANG BIO, INC. (MBIO) reported Operating Lease, Payments of $86.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-19.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:OperatingLeasePayments · last filed 2026-03-19
- MUSTANG BIO, INC. operating lease, payments for the quarter ending 2025-12-31 was $0.00, a 100.00% decline year-over-year.
- MUSTANG BIO, INC. operating lease, payments for the quarter ending 2025-09-30 was $0.00, a 100.00% decline year-over-year.
- MUSTANG BIO, INC. operating lease, payments for the quarter ending 2025-06-30 was $0.00, a 100.00% decline year-over-year.
- MUSTANG BIO, INC. operating lease, payments for the quarter ending 2025-03-31 was $86.00K, a 44.87% decline year-over-year.
- MUSTANG BIO, INC. operating lease, payments for fiscal 2025 was $86.00K, a 83.90% decline from fiscal 2024.
- MUSTANG BIO, INC. operating lease, payments for fiscal 2024 was $534.00K, a 0.95% increase from fiscal 2023.
- MUSTANG BIO, INC. operating lease, payments for fiscal 2023 was $529.00K, a 9.07% increase from fiscal 2022.
- MUSTANG BIO, INC. operating lease, payments for fiscal 2022 was $485.00K, a 0.21% increase from fiscal 2021.
| Period end | Operating Lease, Payments 3 month | Operating Lease, Payments 3 month as first filed | Operating Lease, Payments 6 month | Operating Lease, Payments 9 month | Operating Lease, Payments 12 month |
|---|---|---|---|---|---|
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-19 | $0.00 derived: sum of 2 quarters · filed 2026-03-19 | $0.00 derived: sum of 3 quarters · filed 2026-03-19 | $86.00K 10-K · filed 2026-03-19 | |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $0.00 derived: sum of 2 quarters · filed 2025-11-07 | $86.00K 10-Q · filed 2025-11-07 | $214.00K derived: sum of 4 quarters · filed 2026-03-19 | |
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-08 | $86.00K 10-Q · filed 2025-08-08 | $214.00K derived: sum of 3 quarters · filed 2026-03-19 | $339.00K derived: sum of 4 quarters · filed 2026-03-19 | |
| 2025-03-31 | $86.00K 10-Q · filed 2025-05-14 | $214.00K derived: sum of 2 quarters · filed 2026-03-19 | $339.00K derived: sum of 3 quarters · filed 2026-03-19 | $464.00K derived: sum of 4 quarters · filed 2026-03-19 | |
| 2024-12-31 | $128.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-19 | $253.00K derived: sum of 2 quarters · filed 2026-03-19 | $378.00K derived: sum of 3 quarters · filed 2026-03-19 | $534.00K 10-K · filed 2026-03-19 | |
| 2024-09-30 | $125.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $250.00K derived: sum of 2 quarters · filed 2025-11-07 | $406.00K 10-Q · filed 2025-11-07 | $540.00K derived: sum of 4 quarters · filed 2025-11-07 | |
| 2024-06-30 | $125.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-08 | $281.00K 10-Q · filed 2025-08-08 | $415.00K derived: sum of 3 quarters · filed 2025-08-08 | $678.00K derived: sum of 4 quarters · filed 2025-08-08 | |
| 2024-03-31 | $156.00K 10-Q · filed 2025-05-14 | $290.00K derived: sum of 2 quarters · filed 2025-05-14 | $553.00K derived: sum of 3 quarters · filed 2025-05-14 | $553.00K derived: sum of 4 quarters · filed 2025-05-14 | |
| 2023-12-31 | $134.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-28 | $397.00K derived: sum of 2 quarters · filed 2025-03-28 | $397.00K derived: sum of 3 quarters · filed 2025-03-28 | $529.00K 10-K · filed 2025-03-28 | |
| 2023-09-30 | $263.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08 | $263.00K derived: sum of 2 quarters · filed 2024-11-08 | $395.00K 10-Q · filed 2024-11-08 | $518.00K derived: sum of 4 quarters · filed 2024-11-08 | |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | $132.00K 10-Q · filed 2024-08-13 | $255.00K derived: sum of 3 quarters · filed 2024-08-13 | $489.00K derived: sum of 4 quarters · filed 2024-08-13 | |
| 2023-03-31 | $132.00K 10-Q · filed 2024-05-15 | $255.00K derived: sum of 2 quarters · filed 2024-05-15 | $489.00K derived: sum of 3 quarters · filed 2024-05-15 | $489.00K derived: sum of 4 quarters · filed 2024-05-15 | |
| 2022-12-31 | $123.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-11 | $357.00K derived: sum of 2 quarters · filed 2024-03-11 | $357.00K derived: sum of 3 quarters · filed 2024-03-11 | $485.00K 10-K · filed 2024-03-11 | |
| 2022-09-30 | $234.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $234.00K derived: sum of 2 quarters · filed 2023-11-14 | $362.00K 10-Q · filed 2023-11-14 | $586.00K derived: sum of 4 quarters · filed 2023-11-14 | |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $128.00K 10-Q · filed 2023-08-14 | $352.00K derived: sum of 3 quarters · filed 2023-08-14 | ||
| 2022-03-31 | $128.00K 10-Q · filed 2023-05-12 | $352.00K derived: sum of 2 quarters · filed 2023-05-12 | |||
| 2021-12-31 | $224.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | $484.00K 10-K · filed 2023-03-30 | |||
| 2021-09-30 | $260.00K 10-Q · filed 2022-11-14 | ||||
| 2020-12-31 | $76.00K 10-K · filed 2022-03-23 | ||||
| 2020-03-31 | -$270.00K 10-Q · filed 2020-05-11 | -$174.00K derived: sum of 2 quarters · filed 2021-03-24 | -$242.00K derived: sum of 3 quarters · filed 2021-03-24 | -$122.06K derived: sum of 4 quarters · filed 2021-03-24 | |
| 2019-12-31 | $96.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-24 | $28.00K derived: sum of 2 quarters · filed 2021-03-24 | $147.94K derived: sum of 3 quarters · filed 2021-03-24 | $148.00K 10-K · filed 2021-03-24 | |
| 2019-09-30 | -$68.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | $51.94K derived: sum of 2 quarters · filed 2020-11-06 | $52.00K 10-Q · filed 2020-11-06 | ||
| 2019-06-30 | $119.94K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | $120.00K 10-Q · filed 2019-08-09 | |||
| 2019-03-31 | $60.00 10-Q · filed 2020-05-11 | $59.98K 10-Q · filed 2019-05-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B |